financetom
Business
financetom
/
Business
/
Yum Brands Insider Sold Shares Worth $384,480, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Yum Brands Insider Sold Shares Worth $384,480, According to a Recent SEC Filing
Mar 7, 2025 8:25 AM

11:08 AM EST, 03/07/2025 (MT Newswires) -- David W Gibbs, Director, Chief Executive Officer, on March 06, 2025, sold 2,403 shares in Yum Brands ( YUM ) for $384,480. Following the Form 4 filing with the SEC, Gibbs has control over a total of 223,786 common shares of the company, with 157,893 shares held directly and 65,893 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1041061/000112760225008655/xslF345X05/form4.xml

Price: 161.78, Change: +2.52, Percent Change: +1.58

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Sarepta Shares Fall Following Elevidys Shipment Suspension After Another Death From Acute Liver Failure
Sarepta Shares Fall Following Elevidys Shipment Suspension After Another Death From Acute Liver Failure
Jun 16, 2025
06:21 AM EDT, 06/16/2025 (MT Newswires) -- Sarepta Therapeutics ( SRPT ) shares were down 37% in recent premarket activity Monday, a day after the company said it's temporarily suspending shipments of Elevidys for non-ambulatory patients with Duchenne muscular dystrophy following a second reported case of acute liver failure resulting in death. The company said Sunday that the shipments will...
Sprott Physical Uranium Trust Signs US$100 Million Bought Deal Financing
Sprott Physical Uranium Trust Signs US$100 Million Bought Deal Financing
Jun 16, 2025
06:15 AM EDT, 06/16/2025 (MT Newswires) -- Sprott Inc. ( SII ) , on behalf of the Sprott Physical Uranium Trust (U-UN.TO), on Monday announced a bought deal financing agreement expected to raise approximately US$100 million. Sprott entered an agreement with Canaccord Genuity, under which Canaccord as the underwriter agreed to purchase on a bought deal basis 5.8 million units...
Regeneron Pharmaceuticals Loses Bid as 23andMe to Sell Core Assets to TTAM for $305 Million
Regeneron Pharmaceuticals Loses Bid as 23andMe to Sell Core Assets to TTAM for $305 Million
Jun 16, 2025
06:19 AM EDT, 06/16/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) was edged out in a final bidding round as 23andMe Holding agreed to sell nearly all of its assets to TTAM Research Institute for $305 million, 23andMe said Friday. TTAM, a non-profit led by 23andMe co-founder and former Chief Executive Anne Wojcicki, won the deal following a court-supervised...
Copyright 2023-2026 - www.financetom.com All Rights Reserved